Systematic analysis of microorganisms' metabolism for selective targeting

Area of Science:

• Computational Biology
• Drug Discovery
• Systems Biology

Background:

• Broad-spectrum antibiotics can cause significant side effects.
• Targeting multiple essential pathways in pathogens enhances treatment efficacy, especially against drug-resistant strains.
• Developing organism-specific drugs requires precise identification of unique microbial targets.

Purpose of the Study:

• To identify multi-target and organism-specific potential drug candidates by combining synthetic lethality with selective drug targeting.
• To systematically analyze genome-scale metabolic models of microorganisms to discover novel therapeutic targets.
• To design narrow-spectrum drugs that selectively damage target pathogens while sparing beneficial or non-target organisms.

Main Methods:

• Systematic analysis of genome-scale metabolic models for six different microorganisms.
• Design of 665 individual case studies considering microorganisms as targeted or conserved groups.
• Identification of single essential reactions and synthetic lethal reaction sets (double, triple, quadruple) that are lethal to target organisms and neutral to conserved ones.

Main Results:

• The number of identified synthetic lethal sets varied based on the genomic similarity between microorganisms.
• Key metabolic subsystems identified as crucial for drug targeting include cell envelope biosynthesis, glycerophospholipid metabolism, membrane lipid metabolism, and the nucleotide salvage pathway.
• Two sets of potential drug targets were proposed to address a substantial portion of the analyzed cases.

Conclusions:

• The study provides valuable insights into designing narrow-spectrum drugs with reduced side effects.
• The identified synthetic lethal targets offer a promising strategy for developing novel antimicrobial therapies.
• This systems biology approach facilitates the discovery of organism-specific drug candidates for combating infectious diseases.